Monoclonal proteins after stem cell transplant may predict survival

08/26/2013 | MyelomaBeacon.com

Multiple myeloma patients whose monoclonal protein levels were declining 100 days after autologous stem cell trans­planta­tion survived longer overall and without disease progression, Mayo Clinic researchers found. The presence of lgG-type M proteins and myeloma cell levels of 3% or lower were linked with future continued response, according to the retrospective analysis in the journal Blood.

View Full Article in:

MyelomaBeacon.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN